title: High ability to predict the treatment outcome of peginterferon and ribavirin combination therapy based on the reduction in HCV RNA levels at 4 weeks after starting therapy and amino acid substitutions in the hepatitis C virus in patients infected with HCV genotype 1b.
authors.affiliation: Department of Gastroenterology, Ogaki Municipal Hospital, 4-86 Minaminokawa, Ogaki, Gifu 503-8502, Japan. hmtoyoda@spice.ocn.ne.jp
authors.forename: Hidenori
authors.initials: H
authors.lastname: Toyoda
authors.forename: Takashi
authors.initials: T
authors.lastname: Kumada
authors.forename: Seiki
authors.initials: S
authors.lastname: Kiriyama
authors.forename: Makoto
authors.initials: M
authors.lastname: Tanikawa
authors.forename: Yasuhiro
authors.initials: Y
authors.lastname: Hisanaga
authors.forename: Akira
authors.initials: A
authors.lastname: Kanamori
authors.forename: Toshifumi
authors.initials: T
authors.lastname: Tada
authors.forename: Takahiro
authors.initials: T
authors.lastname: Arakawa
authors.forename: Masashi
authors.initials: M
authors.lastname: Fujimori
authors.forename: Takuro
authors.initials: T
authors.lastname: Niinomi
authors.forename: Naoto
authors.initials: N
authors.lastname: Ando
authors.forename: Satoshi
authors.initials: S
authors.lastname: Yasuda
authors.forename: Keisuke
authors.initials: K
authors.lastname: Sakai
authors.forename: Jun
authors.initials: J
authors.lastname: Kimura